OUP user menu

★ Editor's Choice ★

Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies

Francesco P. Cappuccio, Daniel Cooper, Lanfranco D'Elia, Pasquale Strazzullo, Michelle A. Miller
DOI: http://dx.doi.org/10.1093/eurheartj/ehr007 1484-1492 First published online: 8 February 2011


Aims To assess the relationship between duration of sleep and morbidity and mortality from coronary heart disease (CHD), stroke, and total cardiovascular disease (CVD).

Methods and results We performed a systematic search of publications using MEDLINE (1966–2009), EMBASE (from 1980), the Cochrane Library, and manual searches without language restrictions. Studies were included if they were prospective, follow-up >3 years, had duration of sleep at baseline, and incident cases of CHD, stroke, or CVD. Relative risks (RR) and 95% confidence interval (CI) were pooled using a random-effect model. Overall, 15 studies (24 cohort samples) included 474 684 male and female participants (follow-up 6.9–25 years), and 16 067 events (4169 for CHD, 3478 for stroke, and 8420 for total CVD). Sleep duration was assessed by questionnaire and incident cases through certification and event registers. Short duration of sleep was associated with a greater risk of developing or dying of CHD (RR 1.48, 95% CI 1.22–1.80, P < 0.0001), stroke (1.15, 1.00–1.31, P = 0.047), but not total CVD (1.03, 0.93–1.15, P = 0.52) with no evidence of publication bias (P = 0.95, P = 0.30, and P = 0.46, respectively). Long duration of sleep was also associated with a greater risk of CHD (1.38, 1.15–1.66, P = 0.0005), stroke (1.65, 1.45–1.87, P < 0.0001), and total CVD (1.41, 1.19–1.68, P < 0.0001) with no evidence of publication bias (P = 0.92, P = 0.96, and P = 0.79, respectively).

Conclusion Both short and long duration of sleep are predictors, or markers, of cardiovascular outcomes.

  • Sleep duration
  • Cardiovascular disease
  • Meta-analysis


Quantity and quality of sleep show secular trends alongside changes in modern society requiring longer hours of work, more shift-work, and 24-7 availability of commodities, reducing the average duration of sleep across westernized populations with increased reporting of fatigue, tiredness, and excessive daytime sleepiness.1 Lack of sleep exerts deleterious effects on a variety of systems with detectable changes in metabolic, endocrine2 and immune pathways.3 Too little or too much sleep are associated with adverse health outcomes, including total mortality,4 type 2 diabetes,5 hypertension6,7 and respiratory disorders,8 obesity in both children and adults,9 and poor self-rated health.10 The relationship between duration of sleep and vascular events is U-shaped, suggesting that different mechanisms may operate at either end of the distribution of sleep duration.11

The aims of this study were to systematically review prospective population-based studies, to carry out a meta-analysis to assess the evidence in support of the presence of a relationship between either short or long duration of sleep and incidence of CHD, stroke, and total cardiovascular disease (CVD) and to obtain a quantitative estimate of the risk.


A systematic review and meta-analysis was carried out with methods described in detail elsewhere.4 In brief, we searched longitudinal population studies (published up to June 2009) reporting the association between duration of sleep and fatal and non-fatal coronary heart disease (CHD), stroke, and total CVD events (Supplementary material online, Appendix S1). Studies met the following criteria: original article, prospective cohort design, assessment of duration of sleep as baseline exposure, cause-specific death or non-fatal incident case of CHD, stroke or CVD recorded prospectively as outcome, follow-up of at least 3 years, adult population, and indication of the number of subjects exposed and of the rate or number of events in different sleep duration categories. Studies were excluded if a case–control design was used. If multiple published reports from the same study were available, we included only the one with the most detailed information for both exposure and outcome. Data were extracted independently by two investigators (F.P.C. and D.C.) and differences were resolved by discussion with a third investigator (M.A.M.). In each study, we identified the reference category, being 7–8 h per night in the majority of studies (Table 1 and Figures 13). In most studies, ‘short’ sleep was defined as ≤5–6 h per night and ‘long’ sleep as >8–9 h per night.

View this table:
Table 1

Description of the studies included in the meta-analysis

AuthorYear, publicationCountryCohortYear, baselineSleep categoryTotal events CHD/stroke/CVDAge (years)Quality Score12Exposure assessmentOutcome assessmentAdjusted variables
Qureshi1997USANHANES I (NHEFS)1982<6 h413/285/—31+a17QuestionnaireHospitalizations and death certificatesAge, sex, race, BMI, education, smoking, SBP, cholesterol, diabetes
>8 h
Heslop2002ScotlandScottish workplaces1970–74<7 h—/—/1182<6616QuestionnaireDeath certificateAge, marital status, social class, risk factors, self-perceived stress
>8 h—/—/117
Mallon2002SwedenCounty of Dalarna1983<6 h71/—/—45–6518QuestionnaireDeath certificateAge
>8 h20/—/—
Ayas2003USANurses’ Health Study1986≤5 h934/—/—40–65b18QuestionnaireNational Death Index plus Medical RecordsAge, shift work, high cholesterol, BMI, diabetes, hypertension, smoking, snoring, exercise, alcohol consumption, depression, aspirin use, HRT, FH of MI
>9 h
Burazeri2003IsraelKiryat Yovel Community Health Study1985–88—/—/7750+17QuestionnaireDeath certificateAge, sex, social class, country origin, smoking, alcohol use, physical activity, self appraised health status, diabetes, CHD, stroke, congestive heart failure, blood pressure, BMI, serum glucose, creatinine, albumin, total and HDL cholesterol. thiocyanate, plasma homocysteine
>8 h—/—/93
Amagai2004JapanJichi medical school cohort study1992–95<6 h26/34/—40–6915QuestionnaireDeath certificateAge, SBP, total cholesterol, BMI, smoking, alcohol consumption, education, marital status
≥9 h28/29/—
Patel2004USANurses’ Health Study1986≤5 h—/—/108430–55b17QuestionnaireNational Death IndexAge, smoking, alcohol consumption, physical activity, depression, snoring, BMI, Hx cancer, CVD, hypertension, diabetes, shift work
≥9 h
Ferrie2007EnglandWhitehall II Study1985–88≤5 h—/—/16835–55a18QuestionnaireDeath certificateAge, sex, marital status, employment grade, smoking, physical activity, alcohol consumption, self-rated health, BMI, SBP, total cholesterol, physical illness, GHQ, prevalent CHD
≥9 h
Lan2007TaiwanSurvey of Health and Living Status of the Elderly1993–94<7 h—/—/20964+17QuestionnaireDeath certificateAge, marital status, income, smoking, alcohol, BMI, exercise, depression
≥10 h—/—/170
Meisinger2007GermanyMONICA/KORA Augsburg study1984–95≤5 h295/—/—45–7417QuestionnaireDeath certificate and coronary event registryAge, survey, BMI, education, dyslipidaemia, alcohol intake, FH of MI, physical activity, smoking, hypertension, diabetes, (menopause in women)
≥9 h85/—/—
Chen2008USAWomen's Health Initiative1994–98≤5 h—/1166/—50–79b17QuestionnaireDeath certificate or self-reportingAge, race, socio-economic status, depression, smoking, exercise, hormone replacement, previous CVD, diabetes, hypertension, BMI, high cholesterol
≥10 h
Shankar2008SingaporeSingapore Chinese Health Study1993–99≤5 h846/—/—45–7417QuestionnaireDeath certificateAge, dialect, year of recruitment, BMI, smoking, alcohol intake, physical activity, dietary calories, fruits, vegetables, fibre, fat & cholesterol, vitamin suppl.
≥9 h570/—/—
Ikehara2009JapanJACC study1988–91≤4 h508/1038/229740–7918QuestionnaireDeath certificateAge, BMI, PH of hypertension, diabetes, alcohol, smoking, education, exercise, employment, mental stress, depression, fresh fish intake
>10 h373/926/1990
Stone2009USASOF study1993–94<6 h—/—/72369+b18QuestionnaireDeath certificateAge, BMI, PH diabetes, Parkinson's, dementia, COPD, non-skin cancer, osteoarthritis, CVD, hypertension, walks, alcohol use, smoking, depression, cognitive status, oestrogen and hypnotic use
>8 h
Suzuki2009JapanShizuoka study1999≤5 h—/—/18465–8518QuestionnaireNational Vital Statistics DatabaseAge, sex, smoking, alcohol consumption, BMI, physical activity, SES, mental status, hypertension, diabetes
≥10 h—/—/126
  • aMen and women combined.

  • bWomen only.

Figure 1

Forest plots of the risk of developing or dying of coronary heart disease associated with (A) short duration of sleep compared with the reference group and (B) long duration of sleep compared with the reference group. Results are expressed as relative risk and 95% confidence intervals.

Statistical analysis

Full methods are reported elsewhere.4 The quality of the studies was evaluated by the Downs and Black Quality Index score system.12 Relative risks (RR) or hazard ratios were extracted as a measure of the relationship between sleep duration and incidence of disease. Pooled RR [and 95% confidence interval (CI)] was estimated using a weighted random-effect model. By comparison with the reference category of sleep duration, we estimated the pooled RR (and 95% CI) of disease for the ‘short’ and the ‘long’ sleep category, separately. We tested for heterogeneity among studies,13 publication bias by funnel plot asymmetry and Egger's test.14 We carried out sensitivity and subgroup analyses.4 All statistical analyses were performed using MIX software version 1.7.15 The study adheres to the PRISMA Statement guidelines (Supplementary material online, Appendix S2).


Characteristics of the study cohorts

Fifteen studies were included (Supplementary material online, Appendices S3 and S4). Where results were reported for men and women separately, they were entered into the analyses as separate cohorts. Eleven studies recruited both men and women, whereas four studies only women (Table 1). Nine reported outcomes separately for men and women (18 cohorts). Thus, 24 cohorts were included in the meta-analysis. They included 474 684 participants from eight different countries (five from USA, three from Japan, two from UK, and one from Sweden, Germany, Singapore, Israel, and Taiwan). Follow-up ranged from 6.9 to 25 years. All studies assessed death through death certificates (Table 1). Non-fatal incident cases of vascular events were recorded through disease registers. Sleep duration was assessed by questionnaire in all studies. The total number of events reported was 16 067 (4169 CHD, 3478 stroke, and 8420 total CVD).

Sleep duration and coronary heart disease

In the pooled analysis, short duration of sleep was associated with a greater risk of developing or dying of CHD (RR 1.48, 95% CI 1.22–1.80, P < 0.0001) with no evidence of publication bias (P = 0.95) and some heterogeneity between studies (I2= 44%, Q = 17.7, P = 0.059) (Figure 1A). Long duration of sleep was associated with a greater risk of developing or dying of CHD (1.38, 1.15–1.66, P = 0.0005) with no evidence of publication bias (P = 0.92) and some heterogeneity between studies (I2= 49%, Q = 21.6, P = 0.028) (Figure 1B).

Sleep duration and stroke

In the pooled analysis, short duration of sleep was associated with a greater risk of developing or dying of stroke (RR 1.15, 1.00–1.31, P = 0.047) with no evidence of publication bias (P = 0.30) and no heterogeneity between studies (I2= 0%, Q = 4.34, P = 0.50) (Figure 2A). Long duration of sleep was associated with a greater risk of developing or dying of stroke (1.65, 1.45–1.87, P < 0.0001) with no evidence of publication bias (P = 0.96) and no heterogeneity between studies (I2= 0%, Q = 1.44, P = 0.92) (Figure 2B).

Figure 2

Forest plots of the risk of developing or dying of stroke associated with (A) short duration of sleep compared with the reference group and (B) long duration of sleep compared with the reference group. Results are expressed as relative risk and 95% confidence intervals.

Sleep duration and total cardiovascular disease

In the pooled analysis, short duration of sleep was weakly and not significantly associated with a greater risk of developing or dying of total CVD (RR 1.03, 0.93–1.15, P = 0.52) with no evidence of publication bias (P = 0.46) and no heterogeneity between studies (I2= 0%, Q = 3.42, P = 0.97) (Figure 3A). Long duration of sleep was associated with a greater risk of developing or dying of total CVD (1.41, 1.19–1.68, P < 0.0001) with no evidence of publication bias (P = 0.79) and heterogeneity between studies (I2= 61%, Q = 30.7, P = 0.002) (Figure 3B).

Figure 3

Forest plots of the risk of developing or dying of total cardiovascular disease associated with (A) short duration of sleep compared with the reference group and (B) long duration of sleep compared with the reference group. Results are expressed as relative risk and 95% confidence intervals.

Sources of heterogeneity

For both short and long sleep and in relation to all outcomes considered, the heterogeneity of effect was not due to differences in gender, duration of follow-up, or geographical location (Table 2).

View this table:
Table 2

Subgroup analyses to explore source of heterogeneity

CohortsRR (95% CI), P for heterogeneityCohortsRR (95% CI), P for heterogeneityCohortsRR (95% CI), P for heterogeneity
Short sleep
  Men51.28 (0.74–2.22)21.53 (0.82–2.82)41.00 (0.87–1.15)
  Women51.60 (1.24–2.06)31.21 (0.86–1.70)61.06 (0.91–1.24)
P = 0.48P = 0.51P = 0.57
 Duration of follow-up
  ≤10 years51.49 (1.26–1.75)41.14 (0.93–1.39)51.03 (0.84–1.26)
  >10 years61.36 (0.80–2.32)21.27 (0.82–1.96)61.03 (0.92–1.16)
P = 0.75P = 0.65P = 1.00
  Europe41.33 (0.72–2.46)30.99 (0.86–1.15)
  USA21.35 (1.10–1.65)21.17 (0.97–1.29)21.03 (0.86–1.25)
  East Asia51.68 (1.22–2.31)41.41 (0.95–2.11)61.13 (0.90–1.42)
P = 0.49P = 0.40P = 0.64
Long sleep
  Men51.43 (1.03–2.00)21.63 (1.30–2.05)51.48 (1.00–2.19)
  Women61.43 (1.09–1.89)31.71 (1.43–2.04)71.44 (1.23–1.68)
P = 1.00P = 0.74P = 0.89
 Duration of follow-up
  ≤10 years61.53 (1.18–1.99)41.62 (1.35–1.93)71.53 (1.16–2.02)
  >10 years61.17 (0.95–1.44)21.67 (1.40–2.00)61.34 (1.06–1.70)
P = 0.11P = 0.81P = 0.45
  Europe41.28 (0.92–1.77)51.12 (0.72–1.73)
  USA21.24 (1.00–1.53)21.62 (1.35–1.95)21.39 (1.09–1.77)
  East Asia61.50 (1.11–2.03)41.67 (1.40–1.98)61.59 (1.42–1.78)
P = 0.58P = 0.81P = 0.22


This study shows an increased risk of developing or dying of CHD and stroke on either end of the distribution of sleep duration. Pooled analyses indicate that short sleepers have a greater risk of CHD and stroke than those sleeping 7–8 h per night. Furthermore, long sleepers also show an increased risk for these events, confirming the presence of a U-shape association, with some heterogeneity among studies for CHD and CVD outcomes, no presence of publication bias, high statistical power, no difference between men and women, or by the duration of follow-up. Results for total cardiovascular events were less consistent with no detectable effect in short sleepers and a statistically significant increased risk in long sleepers.

The associations are consistent in different populations, as suggested by the sensitivity analysis and the absence of publication bias, particularly for the effects in short sleepers across all endpoints and for stroke among long sleepers; moreover, the consistency of the method of assessments of the duration of sleep by questionnaire and outcomes across studies limits the variability due to differences in methods.

The study has limitations: we included adjusted estimates from multivariate models from each contributing study. However, residual confounding and bias remain a possibility. Moreover, the results can only be representative of the studies that have been included and are unable to provide a representative inference of all studies published, but not included. Although there was no statistical evidence of publication bias, some studies could have been missed out from the analysis. Given the conservative random-effects model adopted and in view of the results of numerous subgroup and sensitivity analyses, it is unlikely that any addition to the reviewed studies would have generated summary estimates outside the reported 95% CIs. The studies did not exclude subjects with obstructive sleep apnoea–hypopnoea syndrome (OSAS). These would represent ∼4% of middle-aged men and 2% of middle-aged women.16,17 Obstructive sleep apnoea–hypopnoea syndrome is associated with obesity, disrupted and short sleep, excessive daytime sleepiness, and high rates of morbidity and mortality, predominantly due to CVD.18

Self-reported sleep duration was assessed by questionnaire. This method often did not allow (unless explicitly built as additional questions) to differentiate time asleep from time in bed or to estimate the number and duration of naps. It is not usually feasible to obtain more detailed and objective measures of sleep in large prospective population studies. Sleep diaries, actigraphy, and polysomnography from some large population and small-scale investigations have shown high correlations between subjective estimates of sleep duration and the more direct assessments.19,20 Furthermore, assessments of sleep durations in the primary health-care setting rely on self-reported data from patients.

It is possible that a single measure of exposure may not fully capture the sustained effects of sleep duration over time when relating them to long-term disease incidence. Changes in sleep duration over time may represent a better measure of exposure in this context. Two studies have addressed this issue by measuring changes in sleep duration over time as a proxy for prolonged exposure to short or long sleep duration in relation to vital outcomes.21,22

Our results are, in part, consistent with other evidence of increased risk of cardiovascular risk factors like coronary artery calcifications,23 hypertension,6,7,24 obesity,9 type 2 diabetes5 or impaired glucose control,25 and atherogenic lipid profile26 with shorter duration of sleep. However, in our analysis, while the pooled estimates for CHD and stroke were statistically significant, that for total CVD was not. Residual confounding and lack of specificity of the outcome measures may explain the findings. Short duration of sleep has been recently associated with vascular damage. In the Chicago cohort of the CARDIA study, short duration of sleep measured by actigraphy was associated with a greater 5-year incidence of coronary artery calcifications measured by computed tomography.23 In a population study in Germany, both short and long duration of sleep were associated with an increased risk of atherosclerosis, as measured by the intima–media thickness of the common carotid arteries.27 Finally, recent data from the Whitehall II study suggest that the effect of short sleep on CHD risk may be mediated by poor sleep quality.28

The risk associated with changes in sleep duration varies by gender.7,2932 In our analyses, no gender differences were detected in association with either short or long duration of sleep and cardiovascular outcomes. Ideally, long follow-up durations would be appropriate to assess the influence of sleep duration on health over the life course.33 We excluded a priori short follow-up studies (<3 years) to avoid that disease status might have affected sleep patterns. Furthermore, a stratified analysis by the duration of follow-up was carried out, which did not suggest any trend. We were unable to stratify studies by age bands due to the inconsistent reporting of age in the published reports.

The mechanisms that underlie these associations are not fully understood. Causative mechanisms relating short duration of sleep to adverse health outcomes include reciprocal changes in circulating levels of leptin and ghrelin,34,35 which in turn would increase appetite, caloric intake, reduce energy expenditure,2 and facilitate the development of obesity35 and impaired glycaemic control36 with increased cardiovascular risk. Increased cortisol secretion and altered growth hormone metabolism have also been implicated.37 Low-grade inflammation is also activated during short sleep, with possible implications not only for CVD but also for other chronic conditions including cancer.3

Conversely, no studies published to date have demonstrated a possible mechanism mediating the effect of long duration of sleep as a cause of CVD. The association between long duration of sleep and cardiovascular morbidity and mortality may be explained by residual confounding and co-morbidities3840 In particular, depressive symptoms, low socio-economic status, unemployment, low level of physical activity, and undiagnosed health conditions have all been shown to be associated with long duration of sleep and to confound the association with morbidity and mortality.38,40 It is conceivable that the associations between long duration of sleep and the different cardiovascular outcomes may reflect the role of long sleep as a marker, rather than as a cause, of these chronic conditions.11 A recent intervention study of weight reduction, healthy diet, and increased physical activity showed, compared with a control group, a significant reduction in the 7-year incidence of type-2 diabetes among long sleepers,41 supporting the view that long sleep may be an indicator of risk, reversible upon changes in the risk factors.


Currently, there is no evidence that sleeping habitually between 6 and 8 h per day in an adult is associated with harm and long-term health consequences. However, sleeping 9 h or more per night may represent a useful diagnostic tool for detecting subclinical or undiagnosed co-morbidity. People reporting consistently sleeping 5 h or less per night should be regarded as a higher risk group for cardiovascular morbidity and mortality.

Authors’ contribution

F.P.C. and M.A.M. conceived the study aims and design, contributed to the systematic review and data extraction, performed the analysis and interpreted the results. F.P.C. drafted the manuscript. D.C., L.D., and P.S. contributed to the data extraction, interpretation of results, and to the revision of the manuscript.

Supplementary material

Supplementary material is available at European Heart Journal online.

Conflict of interest: none declared.


This work is part of the Programme ‘Sleep, Health & Society’ of the University of Warwick.


View Abstract